Ipsen
Clinical trials sponsored by Ipsen, explained in plain language.
-
New brain tumor drug tested in japanese children
Disease control Not yet recruitingThis early-stage study aims to check the safety and measure how the body processes the drug tovorafenib in Japanese children and young adults with recurrent low-grade brain tumors that have a specific genetic change (BRAF-altered). All participants will take the drug orally once …
Phase: PHASE1 • Sponsor: Ipsen • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New hope for rare liver disease: major trial tests potential treatment
Disease control Not yet recruitingThis study aims to see if a daily pill called elafibranor can slow down a rare, serious liver disease called Primary Sclerosing Cholangitis (PSC). About 350 adults with PSC will be randomly assigned to take either elafibranor or a placebo (inactive pill) for several years. Resear…
Phase: PHASE3 • Sponsor: Ipsen • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New hope for blood cancer patients after other treatments fail
Disease control Not yet recruitingThis study aims to see how well the drug Tazemetostat works for adults with follicular lymphoma, a slow-growing blood cancer, that has come back or stopped responding to at least two prior treatments. Doctors will observe patients receiving Tazemetostat in real-world settings to …
Sponsor: Ipsen • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC